Suppr超能文献

配对剂成像作为莫氏显微外科手术中的一种快速切缘筛查方法。

Paired-agent imaging as a rapid margin screening method in Mohs micrographic surgery.

作者信息

Torres Veronica C, Hodge Sassan, Levy Joshua J, Vaickus Louis J, Chen Eunice Y, LeBouef Matthew, Samkoe Kimberley S

机构信息

Thayer School of Engineering, Dartmouth College, Hanover, NH, United States.

Geisel School of Medicine, Dartmouth College, Hanover, NH, United States.

出版信息

Front Oncol. 2023 Jun 22;13:1196517. doi: 10.3389/fonc.2023.1196517. eCollection 2023.

Abstract

BACKGROUND

Mohs micrographic surgery is a procedure used for non-melanoma skin cancers that has 97-99% cure rates largely owing to 100% margin analysis enabled by sectioning with real-time, iterative histologic assessment. However, the technique is limited to small and aggressive tumors in high-risk areas because the histopathological preparation and assessment is very time intensive. To address this, paired-agent imaging (PAI) can be used to rapidly screen excised specimens and identify tumor positive margins for guided and more efficient microscopic evaluation.

METHODS

A mouse xenograft model of human squamous cell carcinoma ( = 8 mice, 13 tumors) underwent PAI. Targeted (ABY-029, anti-epidermal growth factor receptor (EGFR) affibody molecule) and untargeted (IRDye 680LT carboxylate) imaging agents were simultaneously injected 3-4 h prior to surgical tumor resection. Fluorescence imaging was performed on main, unprocessed excised specimens and margins (tissue sections tangential to the deep margin surface). Binding potential (BP) - a quantity proportional to receptor concentration - and targeted fluorescence signal were measured for each, and respective mean and maximum values were analyzed to compare diagnostic ability and contrast. The BP and targeted fluorescence of the main specimen and margin samples were also correlated with EGFR immunohistochemistry (IHC).

RESULTS

PAI consistently outperformed targeted fluorescence alone in terms of diagnostic ability and contrast-to-variance ratio (CVR). Mean and maximum measures of BP resulted in 100% accuracy, while mean and maximum targeted fluorescence signal offered 97% and 98% accuracy, respectively. Moreover, maximum BP had the greatest average CVR for both main specimen and margin samples (average 1.7 ± 0.4 times improvement over other measures). Fresh tissue margin imaging improved similarity with EGFR IHC volume estimates compared to main specimen imaging in line profile analysis; and margin BP specifically had the strongest concordance (average 3.6 ± 2.2 times improvement over other measures).

CONCLUSIONS

PAI was able to reliably distinguish tumor from normal tissue in fresh margin samples using the single metric of maximum BP. This demonstrated the potential for PAI to act as a highly sensitive screening tool to eliminate the extra time wasted on real-time pathological assessment of low-risk margins.

摘要

背景

莫氏显微外科手术是一种用于治疗非黑色素瘤皮肤癌的手术方法,其治愈率在97%至99%之间,这主要归功于通过实时、迭代组织学评估进行切片实现的100%切缘分析。然而,该技术仅限于高风险区域的小肿瘤和侵袭性肿瘤,因为组织病理学制备和评估非常耗时。为了解决这个问题,可使用双试剂成像(PAI)来快速筛查切除的标本,并识别肿瘤阳性切缘,以指导更高效的显微镜评估。

方法

对人鳞状细胞癌的小鼠异种移植模型(n = 8只小鼠,13个肿瘤)进行PAI。在手术切除肿瘤前3 - 4小时同时注射靶向(ABY - 029,抗表皮生长因子受体(EGFR)亲和分子)和非靶向(IRDye 680LT羧酸盐)成像剂。对主要的未处理切除标本和切缘(与深部切缘表面相切的组织切片)进行荧光成像。测量每个标本的结合潜力(BP)——一个与受体浓度成正比的量——和靶向荧光信号,并分析各自的平均值和最大值以比较诊断能力和对比度。主要标本和切缘样本的BP和靶向荧光也与EGFR免疫组织化学(IHC)相关。

结果

在诊断能力和对比方差比(CVR)方面,PAI始终优于单独的靶向荧光。BP的平均值和最大值测量的准确率为100%,而靶向荧光信号的平均值和最大值的准确率分别为97%和98%。此外,最大BP在主要标本和切缘样本中的平均CVR最高(平均比其他测量方法提高1.7 ± 0.4倍)。在轮廓分析中,与主要标本成像相比,新鲜组织切缘成像改善了与EGFR IHC体积估计的相似性;切缘BP尤其具有最强的一致性(平均比其他测量方法提高3.6 ± 2.2倍)。

结论

PAI能够使用最大BP这一单一指标在新鲜切缘样本中可靠地区分肿瘤与正常组织。这证明了PAI作为一种高度敏感的筛查工具的潜力,可消除在低风险切缘实时病理评估上浪费的额外时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3641/10325620/e3ab7e23776c/fonc-13-1196517-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验